Stratulat Albulescu advises Morphosis Capital on its investment into DocProcess S.R.L.
Stratulat Albulescu Attorneys at Law has advised Morphosis Capital, a relatively newly established private equity fund focused on growth capital investments in Romanian Small and Medium Enterprises (SMEs), on its proposed investment with DocProcess S.R.L. The target company is a successful tech start-up having developed a cloud finance and accounting automation solution based on Robotic Process Automation and eInvoicing.
This is the first deal for Morphosis Capital, which launched at the end of last year. The fund aims to invest between EUR 5 and 15 million in local small and medium-sized enterprises (SMEs) operating in sectors such as consumer goods (FMCG), healthcare, and the business to business sector (B2B), according to one of the most important business newspapers in Romania, quoting one of the four founders of the private equity fund.
DocProcess was launched in 2005 by two Romanian entrepreneurs, Liviu and Daniela Apolozan. The company has over 3,200 customers, including large corporations like Carrefour, Altex and Flanco. DocProcess has an office with 40 employees in Bucharest and also one with 10 people in Grenoble, France, where a research and development center is located.
The Stratulat Albulescu team was led by Managing Partner Silviu Stratulat together with Managing Associate Cristina Man, supported by Senior Associate Sandra Frunzulica.